Although the exact mechanism for the increased levels of PD-1 and PD-L1 in BRCA1-deficient breast cancers remains elusive, we believe pSTAT3 might play an important role in this as a previous study has indicated that STAT3 activation could be responsible for the increased expression of PD-L146. This evidence concerns the gene PDCD1 and breast carcinoma.